A share price of Guardant Health Inc [GH] is currently trading at $50.57, up 2.10%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GH shares have gain 3.14% over the last week, with a monthly amount glided 25.67%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Guardant Health Inc [NASDAQ: GH] stock has seen the most recent analyst activity on April 10, 2025, when Mizuho initiated its Outperform rating and assigned the stock a price target of $55. Previously, Barclays started tracking the stock with Overweight rating on January 23, 2025, and set its price target to $60. On June 28, 2024, upgrade upgraded it’s rating to Buy but maintained its price target of $36 on the stock. In a note dated December 13, 2023, Wolfe Research initiated an Peer Perform rating.
Guardant Health Inc experienced fluctuations in its stock price throughout the past year between $20.14 and $52.92. Currently, Wall Street analysts expect the stock to reach $52 within the next 12 months. Guardant Health Inc [NASDAQ: GH] shares were valued at $50.57 at the most recent close of the market. An investor can expect a potential return of 2.83% based on the average GH price forecast.
Analyzing the GH fundamentals
Trailing Twelve Months sales for Guardant Health Inc [NASDAQ:GH] were 774.00M which represents 20.76% growth. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at -0.59%, Pretax Profit Margin comes in at -0.54%, and Net Profit Margin reading is -0.54%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is 3.69 and Total Capital is -0.41. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -5.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 48.90 points at the first support level, and at 47.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 51.97, and for the 2nd resistance point, it is at 53.38.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Guardant Health Inc [NASDAQ:GH] is 4.11. In addition, the Quick Ratio stands at 3.76 and the Cash Ratio stands at 3.09. Considering the valuation of this stock, the price to sales ratio is 8.09.
Transactions by insiders
Recent insider trading involved POTTER MYRTLE S, Director, that happened on Jun 18 ’25 when 26.0 shares were purchased. Director, Tariq Musa completed a deal on Jun 18 ’25 to buy 3213.0 shares. Meanwhile, Director CLARK IAN T bought 6672.0 shares on Jun 17 ’25.
